Abstract
Deutetrabenazine (Austedo, Teva Pharmaceuticals) is a deuterated form of tetrabenazine. It is the first deuterated drug to receive US regulatory approval and is approved for treatment of chorea in Huntington's disease and tardive dyskinesia. Two oral single dose studies comparing deutetrabenazine (25 mg) with tetrabenazine (25 mg) in healthy volunteers evaluated the impact of deuteration on pharmacokinetics of the active metabolites, alpha-dihydrotetrabenazine (α-HTBZ) and beta-dihydrotetrabenazine (β-HTBZ), metabolite profile, safety, and tolerability. In the two-way, cross-over study, the mean elimination half-life of deuterated total (α + β)-HTBZ was doubled compared with nondeuterated total (α + β)-HTBZ, with a twofold increase in overall mean exposure (area under the concentration-time curve from zero to infinity (AUC0-inf )) and a marginal increase in mean peak plasma concentration (Cmax ). In the mass balance and metabolite profiling study, there were no novel plasma or urinary metabolites of [14 C]-deutetrabenazine relative to [14 C]-tetrabenazine. Specific deuteration in deutetrabenazine resulted in a superior pharmacokinetic profile and an increased ratio of active-to-inactive metabolites, attributes considered to pro...Continue Reading
References
May 1, 1966·Biochemical Pharmacology·D E SchwartzA Brossi
Jul 20, 1984·European Journal of Pharmacology·D J PettiboneA B Pflueger
Mar 1, 1981·Clinical Pharmacology and Therapeutics·R A HamiltonB J Kline
Jul 1, 1981·Chemical & Pharmaceutical Bulletin·K Mimura, S Baba
Sep 18, 2001·Clinical Therapeutics·A J ClaxtonC Pierce
Feb 16, 2006·Neurology·UNKNOWN Huntington Study Group
Aug 29, 2006·Nuclear Medicine and Biology·Rajesh GoswamiHank F Kung
Feb 3, 2007·Clinical Neuropharmacology·Marina de TommasoPaolo Livrea
Mar 15, 2011·European Journal of Medicinal Chemistry·Zhangyu YaoHongbin Sun
Aug 6, 2011·The AAPS Journal·Leslie Z BenetTudor I Oprea
Jul 21, 2012·Neurology·Melissa J ArmstrongUNKNOWN American Academy of Neurology
Dec 4, 2013·Journal of Medicinal Chemistry·Thomas G Gant
Jul 30, 2014·Expert Opinion on Therapeutic Patents·Graham S Timmins
Jul 6, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN Huntington Study GroupEmily Christopher
Oct 11, 2016·Annals of Neurosciences·Navneet KaurVinod Gauttam
Apr 4, 2018·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Anne P KimTerri L Levien
Citations
Oct 11, 2020·Clinical Pharmacology in Drug Development·Frank SchneiderLaura Rabinovich-Guilatt
Apr 24, 2021·Nuclear Medicine and Biology·Mitchell A KlennerTamim A Darwish
Aug 10, 2021·Issues in Mental Health Nursing·Barbara WarrenJessica Johnson
Aug 19, 2021·Drug Metabolism Reviews·Siva Nageswara Rao GajulaRajesh Sonti
Nov 16, 2021·Clinical Pharmacology in Drug Development·Michael C ChenJason D Lickliter